Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Summary of Effects Of the Adjustment On The Line items Within Consolidated Financial Statements (Detail)

v3.24.1
Summary of Significant Accounting Policies - Summary of Effects Of the Adjustment On The Line items Within Consolidated Financial Statements (Detail) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Jan. 01, 2022
Dec. 31, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Inventories $ 25,382 $ 29,800    
Current assets 45,509 50,622    
Total assets 277,407 303,467    
Accrued and other current liabilities 103,261 74,036    
Current liabilities 125,431 92,566    
Total liabilities 339,073 292,478    
Accumulated deficit (1,327,644) (1,251,023) $ (801,632)  
Total shareholders' deficit (61,666) 10,989 (23,639) $ (23,639)
Total liabilities and shareholders' deficit 277,407 303,467    
Costs and expenses applicable to revenues (96,068) (88,781)    
Gross Profit 63,169 74,432    
Loss from operations (40,710) (112,455)    
Income tax expense 16,700 10,691    
Net Income (Loss) $ (76,621) $ (449,391)    
Earnings Per Share, Basic $ (0.01) $ (0.13)    
Earnings Per Share, Diluted $ (0.01) $ (0.13)    
Previously Reported [Member]        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Accumulated deficit     (800,390)  
Total shareholders' deficit     (22,397)  
Revision of Prior Period, Adjustment [Member]        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Accumulated deficit     (1,242)  
Total shareholders' deficit     $ (1,242)